Vigonvita Life Sciences Co., Ltd. (HKG:2630)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
75.20
+2.35 (3.23%)
Nov 17, 2026, 4:08 PM HKT

Vigonvita Life Sciences Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23
12,60313,718--
Market Cap Growth
10.26%---
Enterprise Value
13,11314,171--
Last Close Price
72.8581.85--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23
PS Ratio
49.81120.74--
PB Ratio
50.4528.29--
P/TBV Ratio
89.6632.57--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23
EV/Sales Ratio
51.84124.73--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
4.221.483.051.71
Debt / EBITDA Ratio
---13.34
Net Debt / Equity Ratio
2.230.302.181.20
Net Debt / EBITDA Ratio
-1.88-0.41-1.6715.93
Net Debt / FCF Ratio
-1.78-0.50-1.64-4.01
Asset Turnover
-0.100.02-
Inventory Turnover
-2.601.11-
Quick Ratio
0.981.050.460.56
Current Ratio
1.001.070.500.58
Return on Equity (ROE)
--123.98%-132.51%-
Return on Assets (ROA)
--20.73%-18.15%-
Return on Capital Employed (ROCE)
-33.50%-43.70%-50.40%1.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23
Earnings Yield
-2.91%-2.89%--
FCF Yield
-2.35%-2.08%--
Buyback Yield / Dilution
-11.59%-4.87%-0.69%-